Abstract:Background: LncRNA hypoxia-inducible factor-2 alpha (HIF-2 alpha) promoter upstream transcript (HIF2PUT) functions as a novel regulatory factor of osteosarcoma stem cells partly by controlling HIF-2 alpha expression. The aim of this study was to investigate the clinical significance of HIF-2 alpha and HIF2PUT in human osteosarcoma.Materials and methods: Quantitative real-time PCR was performed to detect the expression levels of HIF-2 alpha mRNA and HIF2PUT in 82 surgical specimens of primary osteosarcoma and matched non-cancerous bone tissues. Then, the associations of HIF-2 alpha and/or HIF2PUT expression with various clinicopathological features of osteosarcoma patients were statistically analyzed. Moreover, their prognostic value was further evaluated.Results: Compared with non-cancerous bone tissues, HIF-2 alpha mRNA and HIF2PUT expression were both significantly upregulated in osteosarcoma tissues (all P < 0.001). Interestingly, the expression levels of HIF-2 alpha mRNA in osteosarcoma tissues were positively correlated with those of HIF2PUT (r = 0.28, P = 0.009). Additionally, osteosarcoma patients with HIF-2 alpha mRNA and/or HIF2PUT over-expression more frequently had large tumor size (all P < 0.05), advanced clinical stage (all P < 0.01) and positive distant metastasis (all P < 0.01). Moreover, osteosarcoma patients with HIF-2 alpha mRNA and/or HIF2PUT over-expression had a significantly shorter overall and disease-free survival (all P < 0.05). Furthermore, Cox multivariate analysis identified that HIF-2 alpha mRNA and/or HIF2PUT expression, clinical stage and distant metastasis were all independent and significant prognostic factors for both overall and disease-free survival (all P < 0.05).Conclusions: HIF-2 alpha and HIF2PUT upregulation may be a common feature in human osteosarcomas with aggressive pbtency. The over-expression of the two molecules, alone or combined, may predict poor prognosis in osteosarcoma patients. (C) 2016 Published by Elsevier GmbH.

Expressions of HIF - 1α and CXCR4 in osteosarcoma and the significance

Expression of CXCL12-CXCR4 in Osteosarcoma and Its Correlation with Angiogenesis

Overexpression of Hypoxia-Inducible Factor-1 Alpha in Human Osteosarcoma: Correlation with Clinicopathological Parameters and Survival Outcome

Expression of Chemokine CXCL14 in Primary Osteosarcoma and Its Association with Prognosis

The clinical value of CXCR4, HER2 and CD44 in human osteosarcoma: A pilot study.

The HIF-1α/CXCR4 Pathway Supports Hypoxia-Induced Metastasis of Human Osteosarcoma Cells.

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma

Expression of Hypoxia-Inducible Factor 1α in Osteosarcoma and Its Value in Predicting Chemosensitivity

Aberrant CXCR4 and Β-Catenin Expression in Osteosarcoma Correlates with Patient Survival.

Relationship of the expression of iNOS and HIF-1α with angiogenesis in osteosarcoma

Relationship of the Expression of HIF-1α and GLUT-1 with Angiogenesis in Osteosarcoma

Expression and Significance of Hypoxemia-Inducible Factor-1 Alpha in Osteosarcoma of the Jaws

Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.

Expression of HIF-1α and Its Relationship with Angiogenesis in Osteosarcoma

Expression and significance of hypoxia inducible factor-1α in osseous sarcoma of jaws

Increased Expression of Insulin-Like Growth Factor-1 Receptor is Correlated with Tumor Metastasis and Prognosis in Patients with Osteosarcoma

Combined Over-Expression of the Hypoxia-Inducible Factor 2α Gene and Its Long Non-Coding RNA Predicts Unfavorable Prognosis of Patients with Osteosarcoma.

BMPR2 and HIF1-α Overexpression in Resected Osteosarcoma Correlates with Distant Metastasis and Patient Survival

Expressions of MDM2 and VEGF in Osteosarcoma Tissue and Clinical Significances

Clinical Significances of Runx2 and Ezrin Expressions in Osteosarcoma

The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma.